Corrigendum: Untargeted metabolomics identified kynurenine as a predictive prognostic biomarker in acute myocardial infarction

Front Immunol. 2023 Mar 8:14:1163419. doi: 10.3389/fimmu.2023.1163419. eCollection 2023.

Authors

Xiaolin Zhang^{1

2}, Yi Cai², Xu Su², Quanmin Jing², Haiwei Liu², Kun Na², Miaohan Qiu², Xiaoxiang Tian², Dan Liu², Tianxiao Wu³, Chenghui Yan², Yaling Han^{1

2}

Affiliations

¹ Second Affiliated Hospital of Dalian Medical University, Dalian, China.
² Cardiovascular Research Institute and Department of Cardiology, The General Hospital of Northern Theater Command, Shenyang, China.
³ Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, China.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.950441.].

Keywords: Kynurenine; ST-acute myocardial infarction; biomarker; indoleamine-pyrrole 2,3-dioxygenase; metabolites; prognosis.

Copyright © 2023 Zhang, Cai, Su, Jing, Liu, Na, Qiu, Tian, Liu, Wu, Yan and Han.

Publication types

Published Erratum